These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Exploring the P2 and P3 ligand binding features for hepatitis C virus NS3 protease using some 3D QSAR techniques. Wei HY, Lu CS, Lin TH. J Mol Graph Model; 2008 Apr; 26(7):1131-44. PubMed ID: 18024210 [Abstract] [Full Text] [Related]
5. Molecular docking and 3D QSAR studies on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes based on the structural modeling of human CCR5 receptor. Xu Y, Liu H, Niu C, Luo C, Luo X, Shen J, Chen K, Jiang H. Bioorg Med Chem; 2004 Dec 01; 12(23):6193-208. PubMed ID: 15519163 [Abstract] [Full Text] [Related]
6. 3D-QSAR with the aid of pharmacophore search and docking-based alignments for farnesyltransferase inhibitors. Vaidya M, Weigt M, Wiese M. Eur J Med Chem; 2009 Oct 01; 44(10):4070-82. PubMed ID: 19515462 [Abstract] [Full Text] [Related]
7. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments. Pandey G, Saxena AK. J Chem Inf Model; 2006 Oct 01; 46(6):2579-90. PubMed ID: 17125198 [Abstract] [Full Text] [Related]
8. Predicting the MHC-peptide affinity using some interactive-type molecular descriptors and QSAR models. Lin TH. Methods Mol Biol; 2007 Oct 01; 409():247-60. PubMed ID: 18450005 [Abstract] [Full Text] [Related]
9. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling. Zhang Q, Yang J, Liang K, Feng L, Li S, Wan J, Xu X, Yang G, Liu D, Yang S. J Chem Inf Model; 2008 Sep 01; 48(9):1802-12. PubMed ID: 18707092 [Abstract] [Full Text] [Related]
10. Combined 3D-QSAR modeling and molecular docking study on indolinone derivatives as inhibitors of 3-phosphoinositide-dependent protein kinase-1. AbdulHameed MD, Hamza A, Liu J, Zhan CG. J Chem Inf Model; 2008 Sep 01; 48(9):1760-72. PubMed ID: 18717540 [Abstract] [Full Text] [Related]
15. Computational studies of COX-2 inhibitors: 3D-QSAR and docking. Kim HJ, Chae CH, Yi KY, Park KL, Yoo SE. Bioorg Med Chem; 2004 Apr 01; 12(7):1629-41. PubMed ID: 15028256 [Abstract] [Full Text] [Related]
16. 3D-QSAR studies of Checkpoint Kinase Weel inhibitors based on molecular docking, CoMFA and CoMSIA. Yi P, Fang X, Qiu M. Eur J Med Chem; 2008 May 01; 43(5):925-38. PubMed ID: 17698256 [Abstract] [Full Text] [Related]
17. Interpretation of scoring functions using 3D molecular fields. Mapping the diacyl-hydrazine-binding pocket of an insect ecdysone receptor. Bordas B, Belai I, Lopata A, Szanto Z. J Chem Inf Model; 2007 May 01; 47(1):176-85. PubMed ID: 17238263 [Abstract] [Full Text] [Related]
18. Molecular docking and 3D-QSAR studies of Yersinia protein tyrosine phosphatase YopH inhibitors. Hu X, Stebbins CE. Bioorg Med Chem; 2005 Feb 15; 13(4):1101-9. PubMed ID: 15670918 [Abstract] [Full Text] [Related]
19. Molecular docking and 3D-QSAR studies on the binding mechanism of statine-based peptidomimetics with beta-secretase. Zuo Z, Luo X, Zhu W, Shen J, Shen X, Jiang H, Chen K. Bioorg Med Chem; 2005 Mar 15; 13(6):2121-31. PubMed ID: 15727865 [Abstract] [Full Text] [Related]